Evidence map›Paper›PMID 35800748›Full record

ArticleGland surgery2022

Surgical management and prognosis of phyllodes tumors of the breast.

Yashuang Ji, Yuting Zhong, Yiqiong Zheng, Huayu Hu, Ningning Min, Yufan Wei, Rui Geng, Chenyan Hong, Qingyu Guan, Jie Li and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yashuang Ji *School of Medicine, Nankai University, Tianjin, China.
Yuting Zhong *Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Yiqiong Zheng *Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Huayu HuSchool of Medicine, Nankai University, Tianjin, China.
Ningning MinSchool of Medicine, Nankai University, Tianjin, China.
Yufan WeiSchool of Medicine, Nankai University, Tianjin, China.
Rui GengDepartment of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Chenyan HongSchool of Medicine, Nankai University, Tianjin, China.
Qingyu GuanSchool of Medicine, Nankai University, Tianjin, China.
Jie LiDepartment of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Zhili WangDepartment of Ultrasound, Chinese People's Liberation Army General Hospital, Beijing, China.
Yanjun ZhangDepartment of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Xiru LiDepartment of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
People's Liberation Army No. 150 Hospital · CNChinese People's Liberation Army · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Regardless of histological grade, phyllodes tumors (PTs) exhibit the potential of local recurrence. The National Comprehensive Cancer Network (NCCN) recommends wide local excision (WLE) with a 1 cm margin or more for borderline/malignant PTs but excisional biopsy for benign PTs. However, the treatment of benign PTs remains controversial and the clinicopathologic risk factors for the local recurrence is still unclear. Methods: We retrospectively analyzed 238 patients with PTs who underwent surgery at the Chinese PLA General Hospital from January 1, 2006 and April 30, 2020. We stratified our analysis according to histologic grade and explored the clinicopathologic factors to influence local recurrence (LR), including age, histologic grade, history of fibroadenoma, type of surgery [vacuum-assisted biopsy system (VABS), local excision (LE), wide local excision (WLE) and mastectomy]. Results: All 238 cases were categorized as benign (171, 71.8%), borderline (38, 16.0%), or malignant (29, 12.2%). The median follow-up was 50.2 months. In multivariate analysis, histologic grade (P<0.01) and history of fibroadenoma (P<0.01) were independent prognostic factors for LR. No difference existed in the recurrence rate of BPT treated with different surgical procedures (P=0.397), whereas a higher recurrence rate was found in VABS and LE subgroups than in WLE and mastectomy subgroups for borderline/malignant tumors (P<0.01). Conclusions: No association found between surgical modalities and LR rate for BPT. We suggested a "wait-and-watch" policy for patients with unexpected benign subtypes, instead of unnecessary re-excision. In addition, VABS or LE can be treated for BPT with small mass, whereas WLE or even mastectomy should be conducted for borderline/malignant PTs with large mass.

Indexed as

Breasthistologylocal recurrencephyllodes tumorsurgery

Identifiers

PMID35800748
PMCPMC9253188
OpenAlexW4284968766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.